Weighted Average Number of Shares Outstanding, Diluted of ENDRA Life Sciences Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
ENDRA Life Sciences Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • ENDRA Life Sciences Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 761,218, a 208% increase year-over-year.
  • ENDRA Life Sciences Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 202,106, a 5458% increase from 2023.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

ENDRA Life Sciences Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 761,218 +514,402 +208% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q3 2024 246,816 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3

ENDRA Life Sciences Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 202,106 +198,470 +5458% 01 Jan 2024 31 Dec 2024 10-K/A 07 Apr 2025 2024 FY
2023 3,636 01 Jan 2023 31 Dec 2023 10-K/A 07 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.